Dahai Liu
Overview
Explore the profile of Dahai Liu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
121
Citations
994
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhao H, Xiao W, Liu D, Zhao W, Zhou K, Hou L, et al.
Materials (Basel)
. 2025 Feb;
18(4).
PMID: 40004351
The large-scale and engineering preparation of NiPd powder with an excellent structure is crucial for promoting the development of catalytic applications and the utilization of hydrogen energy. In this study,...
2.
Li R, Liu W, Liu D, Jin X, Wang S
Front Pain Res (Lausanne)
. 2024 Dec;
5:1486851.
PMID: 39654800
In clinical terms, chronic pain is the most prevalent sequela resulting from COVID-19, which is induced by the novel coronavirus (SARS-CoV-2), while type 2 diabetes mellitus (T2D) is the most...
3.
Yang F, Lu D, Chen Y, Qi F, Wang X, Li J, et al.
Int J Biol Macromol
. 2024 Nov;
286():137752.
PMID: 39561845
Diabetic patients often struggle with wound healing and are at higher risk of infections, necessitating the development of a stretchable, adhesive hydrogel dressing with antibacterial and angiogenesis-promoting properties. In this...
4.
Wang J, Yang F, Lu D, Wang X, Li J, Fu Q, et al.
Int J Biol Macromol
. 2024 Oct;
282(Pt 1):136716.
PMID: 39427791
Highly substituted perfluoroacylated chitosan can alter the physicochemical properties of chitosan; however, the currently synthesized perfluoroacylated chitosan has a low degree of substitution. In this study, we present a simple...
5.
Zhang L, Liu H, Shen J, Liu W, Liu D, Cheng L, et al.
Immunobiology
. 2024 Aug;
229(5):152839.
PMID: 39094396
4-1BB agonists for cancer immunotherapy have shown good preliminary efficacy in clinical trials, but several of the first-generation 4-1BB agonistic antibodies entering the clinic have failed due to safety issues....
6.
Liu D, Fu Q, Liu L, Li W, Qi F, Liu J, et al.
Front Cell Dev Biol
. 2024 Jul;
12:1396890.
PMID: 38983788
The Juan-Bi decoction (JBD) is a classic traditional Chinese medicines (TCMs) prescription for the treatment of rheumatoid arthritis (RA). However, the active compounds of the JBD in RA treatment remain...
7.
Yan T, Pang X, Liang B, Meng Q, Wei H, Li W, et al.
Hum Genomics
. 2024 Jun;
18(1):65.
PMID: 38886862
Background: Human cytomegalovirus (HCMV) is a herpesvirus that can infect various cell types and modulate host gene expression and immune response. It has been associated with the pathogenesis of various...
8.
Hou J, Lin Y, Zhu C, Chen Y, Lin R, Lin H, et al.
Adv Sci (Weinh)
. 2024 Jun;
11(30):e2402477.
PMID: 38874373
Chondrocyte senescence and reduced lubrication play pivotal roles in the pathogenesis of age-related osteoarthritis (OA). In the present study, highly lubricated and drug-loaded hydrogel microspheres are designed and fabricated through...
9.
Wu D, Wang J, Du X, Cao Y, Ping K, Liu D
J Nanobiotechnology
. 2024 May;
22(1):235.
PMID: 38725031
Different from most of the conventional platforms with dissatisfactory theranostic capabilities, supramolecular nanotheranostic systems have unparalleled advantages via the artful combination of supramolecular chemistry and nanotechnology. Benefiting from the tunable...
10.
Wang Y, Zhou D, Ma H, Liu D, Liang Y, Zhu S
Eur J Nucl Med Mol Imaging
. 2024 Apr;
51(10):2941-2952.
PMID: 38581443
Purpose: The accuracy of surgery for patients with solid tumors can be greatly improved through fluorescence-guided surgery (FGS). However, existing FGS technologies have limitations due to their low penetration depth...